RETRA structure 
             | 
        Common Name | RETRA | ||
|---|---|---|---|---|
| CAS Number | 1036069-26-7 | Molecular Weight | 269.34 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C11H11NO3S2 | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
            Use of RETRARETRA is a mutant p53-dependent activator of p73 that suppresses mutant p53-bearing cancer cells. RETRA increases the expression level of p73, and a release of p73 from the blocking complex with mutant p53, which produces tumor-suppressor effects[1].  | 
    
| Name | 2-(4,5-dihydro-1,3-thiazol-2-ylsulfanyl)-1-(3,4-dihydroxyphenyl)ethanone,hydrochloride | 
|---|---|
| Synonym | More Synonyms | 
| Description | RETRA is a mutant p53-dependent activator of p73 that suppresses mutant p53-bearing cancer cells. RETRA increases the expression level of p73, and a release of p73 from the blocking complex with mutant p53, which produces tumor-suppressor effects[1]. | 
|---|---|
| Related Catalog | |
| References | 
| Molecular Formula | C11H11NO3S2 | 
|---|---|
| Molecular Weight | 269.34 | 
| Exact Mass | 304.99500 | 
| PSA | 120.49000 | 
| LogP | 2.35410 | 
| RETRA hydrochloride | 
| Reactivation of Transcriptional Reporter Activity | 
| RETRA |